Evidence map›Paper›PMID 41612079›Full record

ArticleEuropean radiology2026

Development of a quantitative multiparametric ultrasound and deep learning classifier for the detection of prostate cancer.

Florian Delberghe, Xueting Li, Daniel L van den Kroonenberg, Simona Turco, Wim Zwart, Giuseppe Valvano, Auke Jager, Arnoud W Postema, Hessel Wijkstra, Jorg R Oddens and 1 more

Abstract readMulticenter Study
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Florian Delberghe *Biomedical Diagnostics Lab, Department of Electrical Engineering, Eindhoven University of Technology, Groene Loper 3, 5612 AE, Eindhoven, The Netherlands. f.t.delberghe@tue.nl.ORCID http://orcid.org/0009-0000-2937-9796
Xueting Li *Biomedical Diagnostics Lab, Department of Electrical Engineering, Eindhoven University of Technology, Groene Loper 3, 5612 AE, Eindhoven, The Netherlands.
Daniel L van den KroonenbergAmsterdam UMC, Department of Urology, Boelelaan, 1117, Amsterdam, The Netherlands.
Simona TurcoBiomedical Diagnostics Lab, Department of Electrical Engineering, Eindhoven University of Technology, Groene Loper 3, 5612 AE, Eindhoven, The Netherlands.
Wim ZwartAngiogenesis Analytics, Den Bosch, The Netherlands.
Giuseppe ValvanoAngiogenesis Analytics, Den Bosch, The Netherlands.
Auke JagerAmsterdam UMC, Department of Urology, Boelelaan, 1117, Amsterdam, The Netherlands.
Arnoud W PostemaLeiden University Medical Center, Department of Urology, Leiden, The Netherlands.
Hessel WijkstraBiomedical Diagnostics Lab, Department of Electrical Engineering, Eindhoven University of Technology, Groene Loper 3, 5612 AE, Eindhoven, The Netherlands.
Jorg R OddensAmsterdam UMC, Department of Urology, Boelelaan, 1117, Amsterdam, The Netherlands.
Massimo MischiBiomedical Diagnostics Lab, Department of Electrical Engineering, Eindhoven University of Technology, Groene Loper 3, 5612 AE, Eindhoven, The Netherlands.

Funding

Prostate Cancer Diagnosis by Multiparametric UltrasoundR01CA252311 · NCI · THOMAS JEFFERSON UNIVERSITY · PI FORSBERG, FLEMMING, HALPERN, ETHAN J · 2020 to 2024
$3.0M
National Institutes of Health (NIH) R01CA252311
6 · The paper itself

Abstract

objectivesProstate cancer (PCa) diagnosis is increasingly guided by imaging, with ultrasound (US) emerging as a cost-effective and widely accessible modality. This study develops a deep learning-based classifier predicting the presence of clinically significant (cs)PCa using quantitative features extracted from 3D multiparametric (mp)US. MATERIALS AND

methodsA multicenter prospective cohort of 327 patients with suspicion of PCa underwent transrectal 3D mpUS scanning, including dynamic contrast-enhanced US and shear-wave elastography. Acquisitions were registered to 3D histology from radical prostatectomy, which served as the reference standard for the presence of csPCa. Voxels within lesions with International Society of Urological Pathology (ISUP) Grade Group ≥ 2 were considered malignant, and the rest were benign. A 3D deep learning classifier was trained on quantitative mpUS features to detect csPCa. The classifier was trained and internally evaluated on 250 patients and externally evaluated on 77 patients acquired later. Classifier performance was evaluated per voxel using the area under the receiver operating characteristic curve (ROC AUC).

resultsUsing quantitative mpUS features from 327 patients, the classifier achieved a ROC AUC of 0.87 (95% CI: 0.85-0.89) on the internal evaluation set, using 7-fold cross-validation. On the external evaluation cohort, the classifier achieved a ROC AUC of 0.88 (95% CI: 0.87-0.89).

conclusionThe proposed classifier accurately detects csPCa using quantitative features from 3D mpUS and generalizes well to the external dataset. These results support mpUS as a promising, cost-effective tool for csPCa diagnosis. KEY POINTS: Question: Can quantitative features extracted from 3D multiparametric ultrasound (mpUS) reliably detect clinically significant prostate cancer (csPCa), enabling more accessible and affordable diagnosis?

findingsPredicting csPCa using quantitative multiparametric ultrasound features achieved an area under the receiver operating characteristic curve of 0.87, increasing to 0.88 when externally evaluated. CLINICAL RELEVANCE: Our proposed deep learning-based classifier using quantitative 3D mpUS features accurately detects csPCa, as validated on the largest mpUS prostate dataset to date. This opens the door to ultrasound as an accurate, cost-effective method for csPCa detection.

Indexed as

Deep LearningProstatic NeoplasmsAgedContrast MediaElasticity Imaging TechniquesHumansImage Interpretation, Computer-AssistedImaging, Three-DimensionalMaleMiddle AgedProspective StudiesReproducibility of ResultsROC CurveUltrasonographyContrast MediaClassification.Contrast enhanced ultrasoundMultiparametric ultrasoundProstate cancerShear wave elastography

Identifiers

PMID41612079
PMCPMC13212788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.